Division of Liver Diseases;
Icahn School of Medicine at Mount Sinai;
Icahn Medical Instititute;
Janssen Pharmaceuticals Com-panies;
Division of Janssen Scientific Affairs Inc.;
Genetics and Genomics;
Icahn School of Medicine at Mount Sinai;
持续 virologic 反应; 丙肝病毒; 恶化; Telaprevir; Boceprevir; 三倍治疗; 分类和回归; 不利事件; 真实世界;